ClinicalTrials.Veeva

Menu

Evaluating Cardiovascular Phenotypes Using Induced Pluripotent Stem Cells (iPSC)

S

Scripps Translational Science Institute

Status

Invitation-only

Conditions

Coronary Artery Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01517425
11-5676

Details and patient eligibility

About

This research is being done to understand how changes in DNA may put people at risk for developing coronary artery disease. Stem cells will be made using cells from blood and/or skin biopsy samples. We are trying to understand which specific changes in DNA negatively impact a person's health.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Cases:

  1. Previously enrolled in the CAD module of the Genebank at Scripps Clinic Registry
  2. Eligible to have their blood drawn
  3. Be reliable, cooperative and willing to comply with all protocol-specified procedures
  4. Able to understand and grant informed consent

Controls:

  1. Previously enrolled in the Healthy Elderly Active Longevity (HEAL) Cohort
  2. Eligible to have their blood drawn
  3. Be reliable, cooperative and willing to comply with all protocol-specified procedures
  4. Able to understand and grant informed consent

Exclusion criteria

  1. Unwilling or unable to grant informed consent.
  2. Have a significant medical condition that in the Investigator's opinion may interfere with subject's study participation.

Trial design

200 participants in 2 patient groups

Cases
Description:
Subjects previously enrolled in the Scripps Genebank Study
Controls
Description:
Subjects previously enrolled in the Scripps Healthy Elderly Active Longevity (HEAL) Cohort

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems